Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.
about
New concepts for an old problem: the diagnosis of endometrial hyperplasiaNecrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.Enhanced estrogen-induced proliferation in obese rat endometrium.Discovery of novel second mitochondria-derived activator of caspase mimetics as selective inhibitor of apoptosis protein inhibitors.Expression of matrix metalloproteinase-2 and survivin in endometrioid and nonendometrioid endometrial cancers and clinicopathologic significance.pHH3 and survivin are co-expressed in high-risk endometrial cancer and are prognostic relevantInvolvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome.Aldose reductase inhibition suppresses azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice.Inhibition of apoptosis in Cryptosporidium parvum-infected intestinal epithelial cells is dependent on survivin.Altered PTEN expression; a diagnostic marker for differentiating normal, hyperplastic and neoplastic endometrium.Evaluation of expression of the PTEN gene, oestrogen and progesterone receptors as diagnostic and predictive factors in endometrial cancer.New insights in endometrial carcinogenesis.Traditional Approaches to Molecular Genetic Analysis.Loss of p27 Associated with Risk for Endometrial Carcinoma Arising in the Setting of Obesity.Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma.Kaempferol, a natural dietary flavonoid, suppresses 17β-estradiol-induced survivin expression and causes apoptotic cell death in endometrial cancer
P2860
Q28071864-887698FF-7BEC-4C2E-914B-42CE16F69379Q33611310-C70BAB4C-E361-4E2E-9F34-48D840C0FE83Q33894510-9E142C77-F1F8-4B62-A164-C3C6CBB11CD4Q35119355-DB0AA0AA-7F65-4578-8064-F8AC049BC43FQ35154536-7C75EAB3-E703-4DCC-A465-ED05F814C795Q36075212-DDA46FA1-9B2D-4E94-B5C1-DD7A6EE9ACEEQ36231752-B4483417-AF95-4FDA-A952-E7FC31AAF150Q36585331-5E3AF43F-2EA6-4E0A-A55A-E4A1F7317166Q36804184-EB0B17AF-DE3E-474C-BB48-5D03D66603C6Q37460521-AD88C334-A990-4B3F-92DB-EFA85C6830C1Q37471173-2AB026E6-E858-4211-876D-91ECB46C7A9EQ37959376-E6D71B9B-07AE-43FF-B6E8-D18CB7702102Q39026764-32CBEB5F-4442-4370-8E97-4D6D6CE25557Q39967050-518C8C33-AD9F-4882-BFC2-47B7307B3C68Q54591596-BAD5AFE6-70DF-40A2-B608-F03B3D786B2EQ58573207-19A5502B-9813-40CD-A366-ED9F0A96A91E
P2860
Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Expression of survivin, PTEN a ...... and carcinomatous endometrium.
@ast
Expression of survivin, PTEN a ...... and carcinomatous endometrium.
@en
type
label
Expression of survivin, PTEN a ...... and carcinomatous endometrium.
@ast
Expression of survivin, PTEN a ...... and carcinomatous endometrium.
@en
prefLabel
Expression of survivin, PTEN a ...... and carcinomatous endometrium.
@ast
Expression of survivin, PTEN a ...... and carcinomatous endometrium.
@en
P2093
P1476
Expression of survivin, PTEN a ...... and carcinomatous endometrium
@en
P2093
P304
P356
10.1111/J.1525-1438.2006.00541.X
P577
2006-05-01T00:00:00Z